Skip to content

BULCKUS

Active Private limited companyfounded 2022active for 4 yearsGentbruggestraat 91, 9040 GhentKBO/BCE: BE 0793.127.131

Lifetime

4 annual accounts with figures on one time axis
peak of €267,992 in 2025
€267,992▲ 83.1%
peak of €200,041 in 2025
€200,041▲ 83.3%
peak of €222,303 in 2024
€27,344▼ 87.7%
€141,411▲ 215%
Board2 names since 2022
2 directors and 1 other
Documentsfilings and deeds
09-06-202652 days before the deadline
2025micro format
Gross margin from €146,334 to €267,992Result from €109,149 to €200,041Dividend €395,000Equity from €222,303 to €27,344Debts from €44,897 to €141,411

Key points

from the 2025 annual accounts

Equity

€27,344 from €222,303 in 2024

Equity fell by 88% in 1 year.

Turnover

≈ €410,000 estimated

The accounts state no turnover.

Debts

€141,411 84% of the balance sheet
Suppliers 2%Taxes and wages 25%Other 74%

Of this, €139,160 falls due within a year.

Liquidity

1.20 was 6.23 in 2024

Short-term debts rose from €41,771 to €139,160.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 7 to 52 days before the end of the period.

Position in the sector

16.2%

Lower solvency than 82% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,984 companies had the same profile as BULCKUS has now. Each dot stands for 20 companies, two years later.

94.2%
were still trading
1.9%
stopped another way
3.6%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,984 companies, not a prediction for BULCKUS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 28-10-2022
Director, since 28-10-2022
  • 60 sharesdeed of 03-11-2022
  • 60 sharesdeed of 03-11-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0793127131
Incorporation Founding capital of €1,200, 120 shares · (director) and (director) appointed · 120 shares · published on 03-11-2022 · Gazette deed
First establishment Gentbruggestraat 91, Ghent
All 11 events

Comparable companies

same main activity, similar in size and age
Company
BULCKUS Ghent €168,755 €267,992 16.2% -
Huisarts Ann-Sophie Odeurs Sint-Niklaas €210,190 €233,200 49.2% -
Docteur Bien-Aimé Nivelles €176,939 €235,334 21.0% -
DRCDEVRIES Zonhoven €208,381 €253,658 65.7% -
Dr. Karen Van Langendonck Kortessem €185,814 €267,302 1.1% -
Al-Neama Ashraf Antwerp €139,167 €301,808 65.9% -
HUISARTS KIMBERLY DEVOS Roeselare €186,593 €210,091 64.7% -

These companies have the same main activity as BULCKUS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €139,000 and €210,000, founded between 2021 and 2023.

Official details

Source: KBO
Status
Active since 28-10-2022Normal situation
Activity
General medical practiceNACE 86210and 2 others
Establishment unit
2.337.593.2019040 Ghent, since 28-10-2022
Financial year end
31 December
Peppol
Reachable since 19-11-2025
Company details

Annual accounts 2025

€168,755▼ 36.8%
Filing
Filed on 09-06-2026, 52 days before the end of the filing period
Financials

Insights on BULCKUS

BULCKUS files the micro format. That format states no turnover. The gross margin rose from €17,909 in 2022 to €267,992 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BULCKUS

What is the company number of BULCKUS?
The company number of BULCKUS is 0793.127.131. The VAT number is the same number with BE in front: BE 0793.127.131.
Where is BULCKUS based?
The registered office is at Gentbruggestraat 91, 9040 Ghent.Company details
What does BULCKUS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of BULCKUS?
BULCKUS is a private limited company (BV).
When was BULCKUS founded?
BULCKUS was founded on 28-10-2022.
Is BULCKUS still active?
Yes, BULCKUS is an active enterprise in the KBO register.
What is the turnover of BULCKUS?
The turnover in financial year 2025 is about €410,000. This figure is estimated from the gross margin of €267,992 and 38 comparable companies (NACE 862). It probably lies between €360,000 and €520,000.Financials
Is BULCKUS profitable?
In financial year 2025, BULCKUS made a profit of €200,041.
Where can I find the annual accounts of BULCKUS?
BULCKUS filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BULCKUS due?
BULCKUS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.